Longitudinal Clinical Outcomes After Intra‐Articular Dexamethasone–Lidocaine Injection for Temporomandibular Joint Arthralgia
BACKGROUND: Longitudinal real-world data on intra-articular dexamethasone-lidocaine injection for temporomandibular joint (TMJ) arthralgia remain limited. This study evaluated post-injection clinical trajectories in patients with TMJ arthralgia. METHODS: This retrospective observational study included 191 patients (45.5 ± 20.7 years; 67.5% female) with TMJ arthralgia who received intra-articular dexamethasone-lidocaine injection. Mean follow-up from baseline injection to the last available follow-up was 77.0 ± 82.7 days. Outcomes included visual analogue scale (VAS), comfortable mouth opening (CMO), maximum mouth opening (MMO), pain presence, and pain-location burden. Paired, longitudinal, and final-outcome analyses were performed, with additional exploratory analyses. RESULTS: At first follow-up, VAS decreased from 3.25 ± 1.75 to 2.45 ± 1.67 (change, -0.80 ± 1.44; FDR-adjusted p < 0.001), CMO increased modestly by 0.99 ± 5.98 mm (FDR-adjusted p = 0.015), and pain-location burden decreased by 0.30 ± 0.90 (FDR-adjusted p < 0.001). MMO did not change significantly (FDR-adjusted p = 0.166). Mixed-effects models using actual elapsed time showed decreases in VAS (β = -0.069 per 30 days; FDR-adjusted p = 0.003) and pain-location burden (β = -0.093 per 30 days; FDR-adjusted p < 0.001) and a modest increase in CMO (β = 0.343 mm per 30 days; FDR-adjusted p = 0.001), whereas MMO showed no significant longitudinal change. The absolute VAS decrease was greater in the moderate-to-severe baseline pain group than in the mild pain group (-1.68 ± 1.56 vs. -0.35 ± 1.13; FDR-adjusted p < 0.001). At final follow-up, VAS had decreased from baseline in 53.4% of patients, including 80.0% of those with moderate-to-severe baseline pain (FDR-adjusted p < 0.001). CONCLUSIONS: Intra-articular dexamethasone-lidocaine injection was followed by decreases in pain intensity and pain-location burden and a modest increase in CMO, whereas MMO showed no consistent longitudinal change. These findings support a multidomain approach to assessing clinical trajectories after TMJ injection.
Authors
- Yung‐Kyun Noh (ORCID: https://orcid.org/0000-0002-6372-9267)
- Tae-Seok Kim (ORCID: https://orcid.org/0000-0002-3197-345X)
- Yeon‐Hee Lee (ORCID: https://orcid.org/0000-0001-7323-0411)
Institutions
- Korea Institute for Advanced Study (KR)
- Seoul National University (KR)
- Kyung Hee University (KR)
- Kyung Hee University Dental Hospital (KR)
- Seoul National University Dental Hospital (KR)
- Hanyang University (KR)
Publication Details
- Journal
- Journal of Oral Rehabilitation
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1111/joor.70347
- Primary Topic
- Temporomandibular Joint Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00